scholarly article | Q13442814 |
P2093 | author name string | S P Balcerzak | |
R B Livingston | |||
H A Burris | |||
D R Gandara | |||
J J Crowley | |||
D F Moore | |||
P J Hesketh | |||
H M Gross | |||
S K Williamson | |||
J W Goodwin | |||
D Peereboom | |||
P433 | issue | 4 | |
P921 | main subject | docetaxel | Q420436 |
phase II clinical trial | Q42824440 | ||
P304 | page(s) | 237-241 | |
P577 | publication date | 1999-07-01 | |
P1433 | published in | The Cancer Journal from Scientific American | Q27714220 |
P1476 | title | Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial | |
P478 | volume | 5 |
Q46727425 | A phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer |
Q33929465 | Advanced non-small cell lung carcinoma: the emerging role of docetaxel |
Q35569379 | Chemotherapy for small cell lung cancer: a comprehensive review |
Q33817153 | Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer |
Q37957744 | Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials. |
Q37163139 | Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies |
Q79236016 | Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study |
Q36977870 | Platinum-based chemotherapy for variant castrate-resistant prostate cancer |